• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CPH
Click for more information
2.56% 19.0¢

CRESO PHARMA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CPH Appendix 4G & Corporate Governance Statement27/03/19
CPH Annual Report to shareholders25/03/19
CPH Release of Securities From Voluntary Escrow06/03/19
CPH CEO's Report on Operations & Appendix 4EPRICE SENSITIVE28/02/19
CPH Creso Granted License to Cultivate CannabisPRICE SENSITIVE18/02/19
CPH Strategic Collaboration for CBD products with Hempmate SwitzPRICE SENSITIVE14/02/19
CPH Strategic Collaboration with Burleigh Heads Cannabis13/02/19
CPH Reinstatement to Official QuotationPRICE SENSITIVE12/02/19
CPH Clarification and Reinstatement to TradingPRICE SENSITIVE12/02/19
CPH Suspension Update06/02/19
CPH Suspension from Official QuotationPRICE SENSITIVE04/02/19
CPH Cleansing Statement & Appendix 3B01/02/19
CPH Trading HaltPRICE SENSITIVE01/02/19
CPH Pause In TradingPRICE SENSITIVE01/02/19
CPH Colombian Partnership and Appointment of Medical Advisor01/02/19
CPH Quarterly Update & Appendix 4CPRICE SENSITIVE31/01/19
CPH Placement Update, Cleansing Statement & Appendix 3BPRICE SENSITIVE31/01/19
CPH Creso and CLV Expand the OBMJ Beers to Switzerland30/01/19
CPH Creso Raises $3 Million in Institutional PlacementPRICE SENSITIVE24/01/19
CPH Trading HaltPRICE SENSITIVE22/01/19
CPH Creso Signs Supply Agreement with TerrAscend CanadaPRICE SENSITIVE21/01/19
CPH Creso further builds medical cannabis in NZ with Medleaf09/01/19
CPH Strategic Collaboration in Sri Lanka for Medical CannabisPRICE SENSITIVE07/01/19
CPH Creso builds on Israel's new Med Cannabis export lawPRICE SENSITIVE02/01/19
CPH Settlement of Kunna Canada Acquisition - incl Appendix 3BPRICE SENSITIVE20/12/18
CPH US CBD hemp market opens to CresoPRICE SENSITIVE20/12/18
CPH Update on Creso Pharma Canadian growing facility19/12/18
CPH Secondary Trading Notice & Appendix 3B17/12/18
CPH Commercialisation of Animal Health Products Commences17/12/18
CPH Canada TSX-V Roadshow Presentation04/12/18
CPH Creso Pharma to Dual List on TSX-V CanadaPRICE SENSITIVE03/12/18
CPH Interview with Creso COO28/11/18
CPH Exclusive Distribution Agreement for CPH Veterinary ProductsPRICE SENSITIVE14/11/18
CPH Creso to launch its first medical cannabis product in BrazilPRICE SENSITIVE01/11/18
CPH Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/10/18
CPH CPH Establishes Edible Cannabis Product R&D Centre30/10/18
CPH Appendix 3B - Release from Escrow22/10/18
CPH Change of Company Secretary19/10/18
CPH Cleansing Statement & Appendix 3B - Exercise of Options18/10/18
CPH Creso welcomes legalisation of recreational cannabis, CanadaPRICE SENSITIVE17/10/18
CPH Results of Meeting16/10/18
CPH Appendix 3B11/10/18
CPH Old Boy Mary Jane Beer Launch in London, Berlin09/10/18
CPH Securities to be released from escrow08/10/18
CPH Licence application accepted & Construction Finance LoanPRICE SENSITIVE08/10/18
CPH Change of Registry Address: Automic P/L - Sydney Office28/09/18
CPH FNN Interview with Chief Operating Officer18/09/18
CPH Appendix 3B - Quotation of Options12/09/18
CPH Appendix 3B - Options Entitlement Issue Shortfall11/09/18
CPH Update on Colombian Acquisition & Notice of General MeetingPRICE SENSITIVE11/09/18
CPH Creso Pharma Lifestyle Portfolio UpdatePRICE SENSITIVE05/09/18
CPH Quotation of Entitlement Issue Options31/08/18
CPH Half Yearly Report and AccountsPRICE SENSITIVE28/08/18
CPH Appendix 3B - Quotation of Options28/08/18
CPH Appendix 3Y x 4 - Options Entitlement Issue27/08/18
CPH Appendix 3B21/08/18
CPH UK commercialisation of cannaQIX with PharmacarePRICE SENSITIVE21/08/18
CPH Entitlement Issue Shortfall NoticePRICE SENSITIVE17/08/18
CPH Commercial agreement for cannaQIX in Austria & East EuropePRICE SENSITIVE14/08/18
CPH Dispatch of Entitlement Issue Prospectus03/08/18
CPH Creso to launch cannaQIX in Israel and the Middle EastPRICE SENSITIVE02/08/18
CPH Quarterly Activities Report & Appendix 4CPRICE SENSITIVE31/07/18
CPH Appendix 3Y - Vesting of Performance Rights30/07/18
CPH Cleansing Statement & Appendix 3B27/07/18
CPH Entitlement Issue - Letter to Option holders26/07/18
CPH Entitlement Issue - Letter to Ineligible Shareholders26/07/18
CPH Entitlement Issue - Letter to Eligible Shareholders26/07/18
CPH Appendix 3B25/07/18
CPH Prospectus - Entitlement IssuePRICE SENSITIVE25/07/18
CPH Investor Presentation25/07/18
CPH Appendix 3Y - Vesting of Performance Rights23/07/18
CPH Conversion of Performance Rights & Appendix 3B23/07/18
CPH Options Entitlement IssuePRICE SENSITIVE23/07/18
CPH Creso to finalise Colombian AcquisitionPRICE SENSITIVE23/07/18
CPH Creso now trading on the Frankfurt Stock ExchangePRICE SENSITIVE17/07/18
CPH Appendix 3B16/07/18
CPH Creso launches cannaQIX in New ZealandPRICE SENSITIVE02/07/18
CPH Creso JV launches infused terpene craft beers and beveragesPRICE SENSITIVE25/06/18
CPH Creso welcomes decision to legalise Cannabis use in CanadaPRICE SENSITIVE21/06/18
CPH Creso appoints Chief Operating Officer, Americas14/06/18
CPH Licence to cultivate Medicinal Cannabis in Colombia grantedPRICE SENSITIVE12/06/18
CPH Results of Meeting31/05/18
CPH Update on Colombian AcquisitionPRICE SENSITIVE31/05/18
CPH Commercial start of cannaQIX in BENELUX with first ordersPRICE SENSITIVE21/05/18
CPH Creso expands into Israeli Medical CannabisPRICE SENSITIVE16/05/18
CPH Trading HaltPRICE SENSITIVE14/05/18
CPH Notice of Annual General Meeting02/05/18
CPH Quarterly Activities Report & Appendix 4CPRICE SENSITIVE30/04/18
CPH Global Expansion of anibidiolPRICE SENSITIVE30/04/18
CPH Creso's JV to launch Global Beers and TonicsPRICE SENSITIVE18/04/18
CPH Corporate UpdatePRICE SENSITIVE16/04/18
CPH Update on Colombian AcquisitionPRICE SENSITIVE06/04/18
CPH Creso launches cannaDOL product rangePRICE SENSITIVE15/03/18
CPH Appendix 4G27/02/18
CPH Corporate Governance Statement27/02/18
CPH Annual Report and Appendix 4EPRICE SENSITIVE27/02/18
CPH Creso reports first revenues from cannaQIX and anibidiolPRICE SENSITIVE27/02/18
CPH Completion of Mernova acquisition19/02/18
CPH Market Update on Colombian OperationsPRICE SENSITIVE14/02/18
CPH Mernova UpdatePRICE SENSITIVE13/02/18
CPH Appendix 4G & Corporate Governance Statement
27/03/19
CPH Annual Report to shareholders
25/03/19
CPH Release of Securities From Voluntary Escrow
06/03/19
CPH CEO's Report on Operations & Appendix 4E
28/02/19PRICE SENSITIVE
CPH Creso Granted License to Cultivate Cannabis
18/02/19PRICE SENSITIVE
CPH Strategic Collaboration for CBD products with Hempmate Switz
14/02/19PRICE SENSITIVE
CPH Strategic Collaboration with Burleigh Heads Cannabis
13/02/19
CPH Reinstatement to Official Quotation
12/02/19PRICE SENSITIVE
CPH Clarification and Reinstatement to Trading
12/02/19PRICE SENSITIVE
CPH Suspension Update
06/02/19
CPH Suspension from Official Quotation
04/02/19PRICE SENSITIVE
CPH Cleansing Statement & Appendix 3B
01/02/19
CPH Trading Halt
01/02/19PRICE SENSITIVE
CPH Pause In Trading
01/02/19PRICE SENSITIVE
CPH Colombian Partnership and Appointment of Medical Advisor
01/02/19
CPH Quarterly Update & Appendix 4C
31/01/19PRICE SENSITIVE
CPH Placement Update, Cleansing Statement & Appendix 3B
31/01/19PRICE SENSITIVE
CPH Creso and CLV Expand the OBMJ Beers to Switzerland
30/01/19
CPH Creso Raises $3 Million in Institutional Placement
24/01/19PRICE SENSITIVE
CPH Trading Halt
22/01/19PRICE SENSITIVE
CPH Creso Signs Supply Agreement with TerrAscend Canada
21/01/19PRICE SENSITIVE
CPH Creso further builds medical cannabis in NZ with Medleaf
09/01/19
CPH Strategic Collaboration in Sri Lanka for Medical Cannabis
07/01/19PRICE SENSITIVE
CPH Creso builds on Israel's new Med Cannabis export law
02/01/19PRICE SENSITIVE
CPH Settlement of Kunna Canada Acquisition - incl Appendix 3B
20/12/18PRICE SENSITIVE
CPH US CBD hemp market opens to Creso
20/12/18PRICE SENSITIVE
CPH Update on Creso Pharma Canadian growing facility
19/12/18
CPH Secondary Trading Notice & Appendix 3B
17/12/18
CPH Commercialisation of Animal Health Products Commences
17/12/18
CPH Canada TSX-V Roadshow Presentation
04/12/18
CPH Creso Pharma to Dual List on TSX-V Canada
03/12/18PRICE SENSITIVE
CPH Interview with Creso COO
28/11/18
CPH Exclusive Distribution Agreement for CPH Veterinary Products
14/11/18PRICE SENSITIVE
CPH Creso to launch its first medical cannabis product in Brazil
01/11/18PRICE SENSITIVE
CPH Quarterly Activities Report and Appendix 4C
31/10/18PRICE SENSITIVE
CPH CPH Establishes Edible Cannabis Product R&D Centre
30/10/18
CPH Appendix 3B - Release from Escrow
22/10/18
CPH Change of Company Secretary
19/10/18
CPH Cleansing Statement & Appendix 3B - Exercise of Options
18/10/18
CPH Creso welcomes legalisation of recreational cannabis, Canada
17/10/18PRICE SENSITIVE
CPH Results of Meeting
16/10/18
CPH Appendix 3B
11/10/18
CPH Old Boy Mary Jane Beer Launch in London, Berlin
09/10/18
CPH Securities to be released from escrow
08/10/18
CPH Licence application accepted & Construction Finance Loan
08/10/18PRICE SENSITIVE
CPH Change of Registry Address: Automic P/L - Sydney Office
28/09/18
CPH FNN Interview with Chief Operating Officer
18/09/18
CPH Appendix 3B - Quotation of Options
12/09/18
CPH Appendix 3B - Options Entitlement Issue Shortfall
11/09/18
CPH Update on Colombian Acquisition & Notice of General Meeting
11/09/18PRICE SENSITIVE
CPH Creso Pharma Lifestyle Portfolio Update
05/09/18PRICE SENSITIVE
CPH Quotation of Entitlement Issue Options
31/08/18
CPH Half Yearly Report and Accounts
28/08/18PRICE SENSITIVE
CPH Appendix 3B - Quotation of Options
28/08/18
CPH Appendix 3Y x 4 - Options Entitlement Issue
27/08/18
CPH Appendix 3B
21/08/18
CPH UK commercialisation of cannaQIX with Pharmacare
21/08/18PRICE SENSITIVE
CPH Entitlement Issue Shortfall Notice
17/08/18PRICE SENSITIVE
CPH Commercial agreement for cannaQIX in Austria & East Europe
14/08/18PRICE SENSITIVE
CPH Dispatch of Entitlement Issue Prospectus
03/08/18
CPH Creso to launch cannaQIX in Israel and the Middle East
02/08/18PRICE SENSITIVE
CPH Quarterly Activities Report & Appendix 4C
31/07/18PRICE SENSITIVE
CPH Appendix 3Y - Vesting of Performance Rights
30/07/18
CPH Cleansing Statement & Appendix 3B
27/07/18
CPH Entitlement Issue - Letter to Option holders
26/07/18
CPH Entitlement Issue - Letter to Ineligible Shareholders
26/07/18
CPH Entitlement Issue - Letter to Eligible Shareholders
26/07/18
CPH Appendix 3B
25/07/18
CPH Prospectus - Entitlement Issue
25/07/18PRICE SENSITIVE
CPH Investor Presentation
25/07/18
CPH Appendix 3Y - Vesting of Performance Rights
23/07/18
CPH Conversion of Performance Rights & Appendix 3B
23/07/18
CPH Options Entitlement Issue
23/07/18PRICE SENSITIVE
CPH Creso to finalise Colombian Acquisition
23/07/18PRICE SENSITIVE
CPH Creso now trading on the Frankfurt Stock Exchange
17/07/18PRICE SENSITIVE
CPH Appendix 3B
16/07/18
CPH Creso launches cannaQIX in New Zealand
02/07/18PRICE SENSITIVE
CPH Creso JV launches infused terpene craft beers and beverages
25/06/18PRICE SENSITIVE
CPH Creso welcomes decision to legalise Cannabis use in Canada
21/06/18PRICE SENSITIVE
CPH Creso appoints Chief Operating Officer, Americas
14/06/18
CPH Licence to cultivate Medicinal Cannabis in Colombia granted
12/06/18PRICE SENSITIVE
CPH Results of Meeting
31/05/18
CPH Update on Colombian Acquisition
31/05/18PRICE SENSITIVE
CPH Commercial start of cannaQIX in BENELUX with first orders
21/05/18PRICE SENSITIVE
CPH Creso expands into Israeli Medical Cannabis
16/05/18PRICE SENSITIVE
CPH Trading Halt
14/05/18PRICE SENSITIVE
CPH Notice of Annual General Meeting
02/05/18
CPH Quarterly Activities Report & Appendix 4C
30/04/18PRICE SENSITIVE
CPH Global Expansion of anibidiol
30/04/18PRICE SENSITIVE
CPH Creso's JV to launch Global Beers and Tonics
18/04/18PRICE SENSITIVE
CPH Corporate Update
16/04/18PRICE SENSITIVE
CPH Update on Colombian Acquisition
06/04/18PRICE SENSITIVE
CPH Creso launches cannaDOL product range
15/03/18PRICE SENSITIVE
CPH Appendix 4G
27/02/18
CPH Corporate Governance Statement
27/02/18
CPH Annual Report and Appendix 4E
27/02/18PRICE SENSITIVE
CPH Creso reports first revenues from cannaQIX and anibidiol
27/02/18PRICE SENSITIVE
CPH Completion of Mernova acquisition
19/02/18
CPH Market Update on Colombian Operations
14/02/18PRICE SENSITIVE
CPH Mernova Update
13/02/18PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising! Companies can now raise capital through HotCopper! It’s a development allowing a highly cost-effective service to ASX-listed companies, while opening new investment opportunities to investors.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.